Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Hainan Haiyao Uses Knowshine to Develop Antibiotic Intermediate

publication date: Apr 9, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Hainan Haiyao will invest 20 million RMB ($3.2 million) to develop production technology of 7-ACCA, a cephalosporin antibiotic intermediate, with Shanghai Knowshine. 7-ACCA is the key intermediate of cefaclor. Most of China’s cefaclor is imported because domestic companies cannot produce 7-ACCA. Knowshine, which was established in 2006 in Shanghai’s Zhangjiang Hi-Tech Park, specializes in developing manufacturing methods of APIs and intermediates. More details....

Stock Symbol: (SHE: 000566)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners